Access 13 Verified Employees Profiles for Xellera TherapeuticsUnlock Free Contacts Now
About
Founded in 2018, Xellera operates Hong Kong’s FIRST commercial cGMP facilities for clinical-grade cell and gene therapy (CGT) products in the region approved using the PIC/s guidance.
Specific for the complex manufacturing process of Advanced Therapy Medicinal Products (ATMP).
#Biotechnology #Biomedicine #Precision Medicine #Regenerative Medicine #Cell-based Therapies #Gene-based Therapies